Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 38.0539.68---

What is the latest Price to Cash Earnings (PCE) ratio of MANKIND PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of MANKIND PHARMA is 38.05 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202538.05
Mar202439.68
Mar2023-
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of MANKIND PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 38.05
-4.11
Mar2024 39.68
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of MANKIND PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹94,905.1 Cr -5% 2.3% -5.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,469.0 Cr -2.8% -1% 6.7% Stock Analytics
DIVIS LABORATORIES ₹173,305.0 Cr -3.3% 0.4% -2.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,014.0 Cr -3.1% 2.9% 36.9% Stock Analytics
CIPLA ₹111,388.0 Cr -2.7% 5.3% -6.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,381.0 Cr -4.1% -3.7% 3.7% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-5%

2.3%

-5.4%

SENSEX

-2.4%

-3.7%

-9.2%


You may also like the below Video Courses